logo
How UnitedHealthcare became the face of America's health insurance frustrations

How UnitedHealthcare became the face of America's health insurance frustrations

Business Mayor25-05-2025

Flags fly at half staff outside the United Healthcare corporate headquarters in Minnetonka, Minnesota, Dec. 4, 2024.
Stephen Maturen | Getty Images News | Getty Images
It took six months, countless hours on hold and intervention from state regulators before Sue Cover says she finally resolved an over $1,000 billing dispute with UnitedHealthcare in 2023.
Cover, 46, said she was overbilled for emergency room visits for her and her son, along with a standard ultrasound. While Cover said her family would eventually have been able to pay the sum, she said it would have been a financial strain on them.
Cover, a San Diego benefits advocate, said she had conversations with UnitedHealthcare that 'felt like a circular dance.' Cover said she picked through dense policy language and fielded frequent calls from creditors. She said the experience felt designed to exhaust patients into submission.
'It sometimes took my entire day of just sitting on the phone, being on hold with the hospital or the insurance company,' Cover said.
Cover's experience is familiar to many Americans. And it embodies rising public furor toward insurers and in particular UnitedHealthcare, the largest private health insurer in the U.S., which has become the poster child for problems with the U.S. insurance industry and the nation's sprawling health-care system.
The company and other insurers have faced backlash from patients who say they were denied necessary care, providers who say they are buried in red tape and lawmakers who say they are alarmed by its vast influence.
UnitedHealthcare in a statement said it is working with Cover's provider to 'understand the facts of these claims.' The company said it is 'unfortunate that CNBC rushed to publish this story without allowing us and the provider adequate time to review.' CNBC provided the company several days to review Cover's situation before publication.
Andrew Witty, CEO of UnitedHealthcare's company, UnitedHealth Group, stepped down earlier this month for what the company called 'personal reasons.' Witty had led the company through the thick of public and investor blowback. The insurer also pulled its 2025 earnings guidance this month, partly due to rising medical costs, it said.
UnitedHealth Group is by far the biggest company in the insurance industry by market cap, worth nearly $275 billion. It controls an estimated 15% of the U.S. health insurance market, serving more than 29 million Americans, according to a 2024 report from the American Medical Association. Meanwhile, competitors Elevance Health and CVS Health control an estimated 12% of the market each.
It's no surprise that a company with such a wide reach faces public blowback. But the personal and financial sensitivity of health care makes the venom directed at UnitedHealth unique, some experts told CNBC.
Shares of UnitedHealth Group are down about 40% this year following a string of setbacks for the company, despite a temporary reprieve sparked in part by share purchases by company insiders. In the last month alone, UnitedHealth Group has lost nearly $300 billion of its $600 billion market cap following Witty's exit, the company's rough first-quarter earnings and a reported criminal probe into possible Medicare fraud.
In a statement about the investigation, UnitedHealth Group said, 'We stand by the integrity of our Medicare Advantage program.'
Over the years, UnitedHealthcare and other insurers have also faced numerous patient and shareholder lawsuits and several other government investigations.
UnitedHealth Group is also contending with the fallout from a February 2024 ransomware attack on Change Healthcare, a subsidiary that processes a significant portion of the country's medical claims.
More recently, UnitedHealthcare became a symbol for outrage toward insurers following the fatal shooting of its CEO, Brian Thompson, in December. Thompson's death reignited calls to reform what many advocates and lawmakers say is an opaque industry that puts profits above patients.
The problems go deeper than UnitedHealth Group: Insurers are just one piece of what some experts call a broken U.S. health-care system, where many stakeholders, including drugmakers and pharmacy benefit managers, are trying to balance patient care with making money. Still, experts emphasized that insurers' cost-cutting tactics — from denying claims to charging higher premiums — can delay or block crucial treatment, leave patients with unexpected bills, they say, or in some cases, even mean the difference between life and death.
In a statement, UnitedHealthcare said it is ' unfortunate that CNBC appears to be drawing broad conclusions based on a small number of anecdotes.' What's wrong with the health-care industry
Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange.
Brendan McDermid | Reuters
Frustration with insurers is a symptom of a broader problem: a convoluted health-care system that costs the U.S. more than $4 trillion annually.
U.S. patients spend far more on health care than people anywhere else in the world, yet have the lowest life expectancy among large, wealthy countries, according to the Commonwealth Fund, an independent research group. Over the past five years, U.S. spending on insurance premiums, out-of-pocket co-payments, pharmaceuticals and hospital services has also increased, government data show.
While many developed countries have significant control over costs because they provide universal coverage, the U.S. relies on a patchwork of public and private insurance, often using profit-driven middlemen to manage care, said Howard Lapin, adjunct professor at the University of Illinois Chicago School of Law.
But the biggest driver of U.S. health spending isn't how much patients use care — it's prices, said Richard Hirth, professor of health management and policy at the University of Michigan.
There is 'unbelievable inflation of the prices that are being charged primarily by hospitals, but also drug companies and other providers in the system,' said Sabrina Corlette, co-director of the Center on Health Insurance Reforms at Georgetown University. Read More Microplastics stick around in human airways
Lapin said factors such as overtreatment, fraud, health-care consolidation and administrative overhead raise costs for payers and providers, who then pass those on through higher prices. U.S. prescription drug prices are also two to three times higher than those in other developed countries, partly due to limited price regulation and pharmaceutical industry practices such as patent extensions.
While patients often blame insurers, the companies are only part of the problem. Some experts argue that eliminating their profits wouldn't drastically lower U.S. health-care costs.
Still, UnitedHealthcare and other insurers have become easy targets for patient frustration — and not without reason, according to industry experts.
Their for-profit business model centers on managing claims to limit payouts, while complying with regulations and keeping customers content. That often means denying services deemed medically unnecessary, experts said. But at times, insurers reject care that patients need, leaving them without vital treatment or saddled with hefty bills, they added.
Insurers use tools such as deductibles, co-pays, and prior authorization — or requiring approval before certain treatments — to control costs. Industry experts say companies are increasingly relying on artificial intelligence to review claims, and that can sometimes lead to inaccurate denials.
'It's all part of the same business model — to avoid paying as many claims as possible in a timely fashion,' said Dylan Roby, an affiliate at the UCLA Center for Health Policy Research. How UnitedHealth Group got so powerful
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled 'Hacking America's Health Care: Assessing the Change Healthcare Cyber Attack and What's Next,' in the Dirksen Building in Washington, D.C., on May 1, 2024.
Tom Williams | Cq-roll Call, Inc. | Getty Images
While other private U.S. insurers employ many of the same tactics, UnitedHealth Group appears to have faced the most public backlash due to its size and visibility.
UnitedHealth Group's market value dwarfs the sub-$100 billion market caps of competitors such as CVS, Cigna and Elevance. UnitedHealth Group booked more than $400 billion in revenue in 2024 alone, up from roughly $100 billion in 2012.
It has expanded into many parts of the health-care system, sparking more criticism of other segments of its business — and the company's ability to use one unit to benefit another.
UnitedHealth Group grew by buying smaller companies and building them into its growing health-care business. The company now serves nearly 150 million people and controls everything from insurance and medical services to sensitive health-care data.
UnitedHealth Group owns a powerful pharmacy benefit manager, or PBM, called Optum Rx, which gives it even more sway over the market.
PBMs act as middlemen, negotiating drug rebates on behalf of insurers, managing lists of drugs covered by health plans and reimbursing pharmacies for prescriptions. But lawmakers and drugmakers accuse them of overcharging plans, underpaying pharmacies and failing to pass savings on to patients.
Owning a PBM gives UnitedHealth Group control over both supply and demand, Corlette said. Its insurance arm influences what care is covered, while Optum Rx determines what drugs are offered and at what price. UnitedHealth Group can maximize profits by steering patients to lower-cost or higher-margin treatments and keeping rebates, she said.
The company's reach goes even further, Corlette added: Optum Health now employs or affiliates with about 90,000 doctors — nearly 10% of U.S. physicians — allowing UnitedHealth Group to direct patients to its own providers and essentially pay itself for care.
A STAT investigation last year found that UnitedHealth uses its physicians to squeeze profits from patients. But the company in response said its 'providers and partners make independent clinical decisions, and we expect them to diagnose and document patient information completely and accurately in compliance with [federal] guidelines.'
Other insurers, such as CVS and Cigna, also own large PBMs and offer care services. But UnitedHealth Group has achieved greater scale and stronger financial returns.
'I think the company is certainly best in class when it comes to insurers, in terms of providing profits for shareholders,' said Roby. 'But people on the consumer side probably say otherwise when it comes to their experience.' Backlash against UnitedHealth
UnitedHealth Group Inc. headquarters in Minnetonka, Minnesota.
Mike Bradley | Bloomberg | Getty Images
No one knows exactly how often private insurers deny claims, since they aren't generally required to report that data. But some analyses suggest that UnitedHealthcare has rejected care at higher rates than its peers for certain types of plans.
A January report by nonprofit group KFF found that UnitedHealthcare denied 33% of in-network claims across Affordable Care Act plans in 20 states in 2023, one of the highest rates among major insurers. CVS denied 22% of claims across 11 states, and Cigna denied 21% in eight states.
In a statement, UnitedHealthcare said that the percentage does not reflect the company's overall claims denial rate. It added that those plans represent less than 2% of UnitedHealthcare's total claims.
The company said there is a lack of 'standardization in the industry regarding claim protocols,' which can result in fully paid claims being reported as denials. UnitedHealthcare said claims are approved more than 93% of the time after care is delivered.
In December, the company also pushed back on public criticism around its denial rates, saying it approves and pays about 90% of claims upon submission. UnitedHealthcare's website says the remaining 10% go through an additional review process. The company says its claims approval rate stands at 98% after that review. Read More New NHS centre in Wembley aiming to tackle health inequalities
In addition, UnitedHealth Group is facing lawsuits over denials. In November, families of two deceased Medicare Advantage patients sued the company and its subsidiary, alleging it used an AI model with a '90% error rate' to deny their claims. UnitedHealth Group has argued it should be dismissed from the case because the families didn't complete Medicare's appeals process.
A spokesperson for the company's subsidiary, NaviHealth, also previously told news outlets that the lawsuit 'has no merit' and that the AI tool is used to help providers understand what care a patient may need. It does not help make coverage decisions, which are ultimately based on the terms of a member's plan and criteria from the Centers for Medicare & Medicaid Services, the spokesperson said.
Meanwhile, the reported Justice Department criminal probe outlined by the Wall Street Journal targets the company's Medicare Advantage business practices. In its statement, the company said the Justice Department has not notified it about the reported probe, and called the newspaper's reporting 'deeply irresponsible.'
Inside the company, employees say customers and workers alike face hurdles.
One worker, who requested anonymity for fear of retaliation, said UnitedHealthcare's provider website often includes doctors listed as in-network or accepting new patients when they're not, leading to frequent complaints. Management often replies that it's too difficult to keep provider statuses up to date, the person said.
UnitedHealthcare told CNBC it believes 'maintaining accurate provider directories is a shared responsibility among health plans and providers,' and that it 'proactively verifies provider data on a regular basis.' The vast majority of all inaccuracies are due to errors or lack of up-to-date information submitted by providers, the company added.
Emily Baack, a clinical administrative coordinator at UMR, a subsidiary of UnitedHealthcare, criticized the length of time it can take a provider to reach a real support worker over the phone who can help assess claims or prior authorization requests. She said the company's automated phone system can misroute people's calls or leave them waiting for a support person for over an hour.
But Baack emphasized that similar issues occur across all insurance companies.
She said providers feel compelled to submit unnecessary prior authorization requests out of fear that claims won't be paid on time. Baack said that leads to a massive backlog of paperwork on her end and delays care for patients.
UnitedHealthcare said prior authorization is 'an important checkpoint' that helps ensure members are receiving coverage for safe and effective care.
The company noted it is 'continually taking action to simplify and modernize the prior authorization process.' That includes reducing the number of services and procedures that require prior authorization and exempting qualified provider groups from needing to submit prior authorization requests for certain services. An emerging startup ecosystem
Sheldon Cooper | Sopa Images | Lightrocket | Getty Images
While UnitedHealthcare is not the only insurer facing criticism from patients, Thompson's killing in December reinforced the company's unique position in the public eye. Thousands of people took to social media to express outrage toward the company, sharing examples of their own struggles.
The public's hostile reaction to Thompson's death did not surprise many industry insiders.
Alicia Graham, co-founder and chief operating officer of the startup Claimable, said Thompson's murder was 'a horrible crime.' She also acknowledged that anger has been bubbling up in various online health communities 'for years.'
Claimable is one of several startups trying to address pain points within insurance. It's not an easy corner of the market to enter, and many of these companies, including Claimable, have been using the AI boom to their advantage.
Claimable, founded in 2024, said it helps patients challenge denials by submitting customized, AI-generated appeal letters on their behalf. The company can submit appeals for conditions such as migraines and certain pediatric and autoimmune diseases, though Graham said it is expanding those offerings quickly.
Many patients aren't aware that they have a right to appeal, and those who do can spend hours combing through records to draft one, Graham said. If patients are eligible to submit an appeal letter through Claimable, she said they can often do so in minutes. Each appeal costs users $39.95 plus shipping, according to the company's website.
'A lot of patients are afraid, a lot of patients are frustrated, a lot of patients are confused about the process, so what we've tried to do is make it all as easy as possible,' Graham told CNBC.
Some experts have warned about the possibility of health-care 'bot wars,' where all parties are using AI to try to gain an edge.
Mike Desjadon, CEO of the startup Anomaly, said he's concerned about the potential for an AI arms race in the sector, but he remains optimistic. Anomaly, founded in 2020, uses AI to help providers determine what insurers are and aren't paying for in advance of care, he said.
'I run a technology company and I want to win, and I want our customers to win, and that's all very true, but at the same time, I'm a citizen and a patient and a husband and a father and a taxpayer, and I just want health care to be rational and be paid for appropriately,' Desjadon told CNBC.
Dr. Jeremy Friese, founder and CEO of the startup Humata Health, said patients tend to interact with insurers only once something goes wrong, which contributes to their frustrations. Requirements such as prior authorization can be a 'huge black box' for patients, but they're also cumbersome for doctors, he said.
Friese said his business was inspired by his work as an interventional radiologist. In 2017, he co-founded a prior-authorization company called Verata Health, which was acquired by the now-defunct health-care AI startup Olive. Friese bought back his technology and founded his latest venture, Humata, in 2023.
Humata uses AI to automate prior authorization for all specialties and payers, Friese said. The company primarily works with medium and large health systems, and it announced a $25 million funding round in June.
'There's just a lot of pent-up anger and angst, frankly, on all aspects of the health-care ecosystem,' Friese told CNBC. The Change Healthcare cyberattack
UnitedHealth CEO Andrew Witty testifies before the Senate Finance Committee on Capitol Hill in Washington on May 1, 2024.
Kent Nishimura | Getty Images
UnitedHealth Group also set a grim record last year that did little to help public perception. The company's subsidiary Change Healthcare suffered a cyberattack that affected around 190 million Americans, the largest reported health-care data breach in U.S. history.
Change Healthcare offers payment and revenue cycle management tools, as well as other solutions, such as electronic prescription software. In 2022, it merged with UnitedHealth Group's Optum unit, which touches more than 100 million patients in the U.S.
In February 2024, a ransomware group called Blackcat breached part of Change Healthcare's information technology network. UnitedHealth Group isolated and disconnected the affected systems 'immediately upon detection' of the threat, according to a filing with the U.S. Securities and Exchange Commission, but the ensuing disruption rocked the health-care sector.
Money stopped flowing while the company's systems were offline, so a major revenue source for thousands of providers across the U.S. screeched to a halt. Some doctors pulled thousands of dollars out of their personal savings to keep their practices afloat.
'It was and remains the largest and most consequential cyberattack against health care in history,' John Riggi, the national advisor for cybersecurity and risk at the American Hospital Association, told CNBC.
Ransomware is a type of malicious software that blocks victims from accessing their computer files, systems and networks, according to the Federal Bureau of Investigation. Ransomware groups such as Blackcat, which are often based in countries such as Russia, China and North Korea, will deploy this software, steal sensitive data and then demand a payment for its return.
Ransomware attacks within the health-care sector have climbed in recent years, in part because patient data is valuable and relatively easy for cybercriminals to exploit, said Steve Cagle, CEO of the health-care cybersecurity and compliance firm Clearwater.
'It's been a very lucrative and successful business for them,' Cagle told CNBC. 'Unfortunately, we'll continue to see that type of activity until something changes.'
UnitedHealth Group paid the hackers a $22 million ransom to try to protect patients' data, then-CEO Witty said during a Senate hearing in May 2024.
Sheldon Cooper | Sopa Images | Lightrocket | Getty Images
In March 2024, UnitedHealth Group launched a temporary funding assistance program to help providers with short-term cash flow.
The program got off to a rocky start, several doctors told CNBC, and the initial deposits did not cover their mounting expenses.
UnitedHealth Group ultimately paid out more than $9 billion to providers in 2024, according to the company's fourth-quarter earnings report in January.
Witty said in his congressional testimony that providers would only be required to repay the loans when 'they, not me, but they confirm that their cash flow is normalized.'
Almost a year later, however, the company is aggressively going after borrowers, demanding they 'immediately repay' their outstanding balances, according to documents viewed by CNBC and providers who received funding. Some groups have been asked to repay hundreds of thousands of dollars in a matter of days, according to documents viewed by CNBC.
A spokesperson for Change Healthcare confirmed to CNBC in April that the company has started recouping the loans.
″ We continue to work with providers on repayment and other options, and continue to reach out to those providers that have not been responsive to previous calls or email requests for more information,' the spokesperson said.
The pressure for repayment drew more ire toward UnitedHealth Group on social media, and some providers told CNBC that dealing with the company was a 'very frustrating experience.'
The vast majority of Change Healthcare's services have been restored over the last year, but three products are still listed as 'partial service available,' according to UnitedHealth's cyberattack response website. The road ahead
UnitedHealth Group signage is displayed on a monitor on the floor of the New York Stock Exchange.
Michael Nagle | Bloomberg | Getty Images
Witty's departure and the company's warning about elevated medical costs, combined with the fallout from Thompson's murder and the Change Healthcare cyberattack, could mean UnitedHealth faces an uphill battle.
UnitedHealth Group appears to be trying to regain the public's trust. For example, Optum Rx in March announced plans to eliminate prior authorizations on dozens of drugs, easing a pain point for physicians and patients.
But policy changes at UnitedHealth Group and other insurers may not drastically improve care for patients, health insurance industry experts previously told CNBC.
They said there will need to be structural changes to the entire insurance industry, which will require legislation that may not be high on the priority list for the closely divided Congress.
The spotlight on UnitedHealth Group may only grow brighter in the coming months. The trial date for Luigi Mangione, the man facing federal stalking and murder charges in connection with Thompson's shooting, is expected to be set in December. Mangione has pleaded not guilty to the charges.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Yahoo

time2 hours ago

  • Yahoo

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus

Diplomatic win for UK hosting US-China trade talks
Diplomatic win for UK hosting US-China trade talks

Yahoo

time2 hours ago

  • Yahoo

Diplomatic win for UK hosting US-China trade talks

Sky News understands that the Trump administration approached the UK government to ask if it would host round two of the US-China trade talks. This is a useful 'diplo-win' for the UK. The first round was held in Geneva last month. News of that happening came as a surprise. The Chinese and the Americans were in the midst of a Trump-instigated trade war. President Trump was en route to Saudi Arabia and suddenly we got word of talks in Switzerland. They went surprisingly well. US treasury secretary Scott Bessent and his Chinese counterpart He Lifeng, met face-to-face and agreed to suspend most tariffs for 90 days. But two weeks later, the Trump administration accused Beijing of breaking the agreements reached in Geneva. Beijing threw the blame back at Washington. On Wednesday, Donald Trump and Xi Jinping spoke by phone. The Chinese claimed this call was at the Americans' request. Either way, the consequence was that the talks were back on track. "I just concluded a very good phone call with President Xi of China, discussing some of the intricacies of our recently made, and agreed to, trade deal," President Trump said this week. From that call came the impetus for a second round of talks. A venue was needed. In stepped the UK at short notice. Beyond being geographically convenient, UK government sources suggest that Britain is geopolitically in the right place right now to act as this bridge and facilitator. The UK-China relationship is in the process of a "reset". Other locations, like Brussels or other EU capitals, would have been less workable. Crucially too, for the UK, this is also potentially advantageous as it seeks to get its own UK-US trade agreement, to eliminate or massively reduce tariffs, over the line. Talks on reaching the "implementation phase" have been near-continuous since the announcement last month, but having the American principals in London is a plus. Sideline talks are possible, but even the presence of the US team in the UK is helpful. Read more from Sky News:Man wrongly deported from US to El Salvador has been returned to face criminal chargesMore than 40 'narco-boat' drug smugglers arrested in major police sting For all the chaos that President Trump is causing with his tariffs, he has instigated face-to-face conversations as he seeks resets. Key players are sitting down around tables - yes, to untangle the trade knots which Trump tied, but this whole episode has pulled foes together around the same table; it has forced relationships and maybe mutual understanding. That's useful. And for this next round, between superpowers, the UK is the host. Also useful.

Is a $5,000 DOGE stimulus check a real thing? What we know
Is a $5,000 DOGE stimulus check a real thing? What we know

Yahoo

time2 hours ago

  • Yahoo

Is a $5,000 DOGE stimulus check a real thing? What we know

In February, President Donald Trump said he was considering a plan to pay out $5,000 stimulus checks to American taxpayers from the savings identified by billionaire Elon Musk's Department of Government Efficiency (DOGE). Are they happening? No official plan or schedule for such a payout has been released, and a decision on the checks would have to come from Congress, which has so far been cool to the idea. And there have been questions as to how much DOGE has actually saved. The idea was floated by Azoria investment firm CEO James Fishback, who suggested on Musk's social media platform X that Trump and Musk should "should announce a 'DOGE Dividend'" from the money saved from reductions in government waste and workforce since it was American taxpayer money in the first place. He even submitted a proposal for how it would work, with a timeline for after the expiration of DOGE in July 2026. "At $2 trillion in DOGE savings and 78 million tax-paying households, this is a $5,000 refund per household, with the remaining used to pay down the national debt," he said in a separate post. Musk replied, "Will check with the President." "We're considering giving 20% of the DOGE savings to American citizens and 20% to paying down the debt," Trump said in a during the Saudi-sponsored FII PRIORITY Summit in Miami Beach the same month. DOGE has dismantled entire federal agencies, wiped out government contracts and led the firings of tens of thousands of federal workers, leaving many agencies struggling to continue operations. DOGE checks? Elon Musk dodges DOGE stimulus check question during Wisconsin rally: Here's what he said. Fishbeck suggested that the potential refund go only to households that are net-income taxpayers, or households that pay more in taxes than they get back. The Pew Research Center said that most Americans with an adjusted gross income of under $40,000 effectively pay no federal income tax. They would not be eligible. If DOGE achieves Musk's initial goal of stripping $2 trillion from U.S. government spending by 2026, Fishback's plan was for $5,000 per household, or 20% of the savings divided by the number of eligible households. If DOGE doesn't hit the goal, Fishback said the amount should be adjusted accordingly. 'So again, if the savings are only $1 trillion, which I think is awfully low, the check goes from $5,000 to $2,500,' Fishback said during a podcast appearance. 'If the savings are only $500 billion, which, again, is really, really low, then the [checks] are only $1,250.' However, while Musk talked about saving $2 trillion in federal spending during Trump's campaign, he lowered the goal to $1 trillion after Trump assumed office and said in March he was on pace to hit that goal by the end of May. At a Cabinet meeting in April, Musk lowered the projected savings further to $150 billion in fiscal year 2026. Musk left the White House at the end of May when his designation as a "special government employee" ended. DOGE, the advisory group he created, is expected to continue without him. That depends on who you ask. On its website, DOGE claims to have saved an estimated $175 billion as of May 30, "a combination of asset sales, contract and lease cancellations and renegotiations, fraud and improper payment deletions, grant cancellations, interest savings, programmatic changes, regulatory savings, and workforce reductions." The site says that works out to $1,086.96 saved per taxpayer. However, many of DOGE's claims have been exaggerated and several of the initiatives to slash agency workforces have been challenged in court. DOGE has been accused of taking credit for contracts that were canceled before DOGE was created, failing to factor in funds the government is required to pay even if a contract is canceled, and tallying every contract by the most that could possibly be spent on it even when nothing near that amount had been obligated. The website list has been changed as the media pointed out errors, such as a claim that an $8 million savings was actually $8 billion. On May 30, CNN reported that one of its reporters found that less than half the $175 billion figure was backed up with even basic documentation, making verification difficult if not impossible. Some of the changes may also end up costing taxpayers more, such as proposed slashes to the Internal Revenue Service that experts say would mean less tax revenue generated, resulting in a net cost of about $6.8 billion. Over the next 10 years, if IRS staffing stays low, the cumulative cost in uncollected taxes would hit $159 billion, according to the nonpartisan Budget Lab at Yale University. The per-taxpayer claim on the website is also inflated, CNN said, as it's based on '161 million individual federal taxpayers' and doesn't seem to include married people filing jointly. This article originally appeared on Florida Times-Union: DOGE dividends: Will American taxpayers get a $5,000 check?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store